Los Angeles, CA, United States of America

Dhanalakshmi Kasi

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Molecular Imaging. Top assignees: Siemens Medical Solutions USA, Inc., Eli Lilly and Company. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dhanalakshmi Kasi. Retrieved from https://idiyas.com/inventor/dhanalakshmi-kasi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 85.7


 

Average Co-Inventor Count = 10.8

ph-index = 5

Forward Citations = 73(Granted Patents)


Location History:

  • Silver Spring, MD (US) (2020)
  • Los Angeles, CA (US) (2010 - 2021)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PSMA Imaging Agents
PET Imaging Agents
Neurological Dysfunction
Molecular Imaging Probes
Cyclic Azapeptides
Therapeutic Index
Hypoxia Imaging
Matrix-Metalloproteinase
Targeted Drug Treatment
Integrin Markers
Carbonic Anhydrase-IX
Imaging Agents
21 patents (USPTO):Explore Patents

Title: Innovations in Imaging: The Contributions of Dhanalakshmi Kasi

Introduction

Dhanalakshmi Kasi, based in Los Angeles, CA, is a notable inventor in the field of medical imaging. With a remarkable portfolio comprising 19 patents, Kasi has made significant advancements in the development of imaging agents that enhance the detection of prostate-specific membrane antigen (PSMA). His work is crucial in the realm of oncology, particularly in improving diagnostic capabilities for prostate cancer.

Latest Patents

Kasi's latest patents focus on PSMA imaging agents, which are compounds designed for targeting and imaging the prostate-specific membrane antigen. These patents disclose methods for synthesizing compounds and imaging agents, as well as the innovative techniques for imaging PSMA itself. Notably, the imaging agents developed are suitable for both PET and SPECT imaging, underscoring their versatility in clinical applications.

Career Highlights

Throughout his career, Dhanalakshmi Kasi has contributed his expertise to esteemed companies, including Siemens Medical Solutions USA, Inc. and Eli Lilly and Company. His work in these organizations has facilitated the transition of innovative concepts into practical solutions, reinforcing his role as a leader in medical technology advancements.

Collaborations

Collaboration has been a key component of Kasi's success. He has worked alongside notable professionals such as Joseph C. Walsh and Hartmuth C. Kolb, leveraging their collective knowledge to enhance the development of imaging technologies. These partnerships exemplify the collaborative spirit of innovation that drives the medical field forward.

Conclusion

Dhanalakshmi Kasi's contributions to the field of imaging demonstrate the profound impact of innovation in medicine. With 19 patents to his name, his work on PSMA imaging agents holds promise for enhancing cancer diagnostics and improving patient outcomes. As technology continues to evolve, innovators like Kasi remain instrumental in shaping the future of medical diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…